Stockreport

Intellia Therapeutics beats by $0.06, beats on revenue [Seeking Alpha]

Intellia Therapeutics, Inc.  (NTLA) 
Last intellia therapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intelliatx.com/investor-overview
PDF Intellia Therapeutics beats by $0.06, beats on revenueIntellia Therapeutics (NASDAQ:NTLA): Q3 EPS of -$0.44beats by $0.06.Revenue of $7.32M (+50.3% Y/Y)beats by $1.44M.P [Read more]